GHK-Cu (Copper Tripeptide-1)
Glycyl-histidyl-lysine in complex with copper (II)
At a glance
What it is: Glycyl-histidyl-lysine in complex with copper (II).
Primary research applications:
- Cosmetic skin care (established)
- Wound healing (evidence)
- Hair regrowth (preliminary)
Editorial summary: GHK-Cu has genuine dermatology and wound-healing evidence — it's one of the best-substantiated peptides for topical skin use. Claims about injectable, systemic, or anti-aging effects are much more speculative.
What is GHK-Cu?
GHK (glycyl-L-histidyl-L-lysine) is a naturally occurring tripeptide found in human plasma that binds copper(II) ions with high affinity, forming the complex GHK-Cu. Plasma concentrations decline substantially with age. The molecule has been studied in dermatology and wound healing since the 1970s, and is used in many cosmetic products today.[1]
Mechanism of action
GHK-Cu's proposed mechanisms include:
- Stimulation of dermal fibroblast proliferation and collagen/elastin synthesis
- Improved wound angiogenesis
- Antioxidant effects via copper chemistry
- Upregulation of multiple repair-related genes (demonstrated in microarray studies)
- Anti-inflammatory effects in skin
What the research shows
The peer-reviewed literature on GHK-Cu is summarized below across two tiers: human research (the highest standard), and preclinical / emerging research (animal models and early-stage human work).
Claims and the evidence behind them
This table summarizes commonly discussed claims and how the published evidence weighs in. The aim is clarity — supported claims, claims that look promising but need more data, and claims that outrun the science.
| Claim | What the evidence shows | Verdict |
|---|---|---|
| Improves skin firmness and wrinkle depth topically | Multiple small controlled trials | Supported |
| Accelerates wound healing | Human and animal data | Supported |
| Regrows hair | Preclinical; limited human data | Plausible |
| Has anti-aging systemic effects when injected | No human data | Unsupported |
| Reverses liver fibrosis | Preclinical signal only | Preliminary |
Reported user experiences
How the research describes administration
Topical formulations in cosmetic and medical products are well-established. Subcutaneous injection is used in grey-market settings but lacks human clinical validation.
Editorial note
Administration details above describe how the peptide is given in published studies. We summarize this for educational completeness — these descriptions are not protocols, dosing recommendations, or instructions for personal use. Decisions about treatment require an appropriately licensed clinician.
Safety considerations and open questions
The takeaway
GHK-Cu is a rare case of a peptide with legitimate topical dermatology and wound-healing evidence. For cosmetic use as directed, the risk is low and the short-term benefits are reasonably supported. The further you get from topical application — and into injectable, systemic, or anti-aging claims — the thinner the evidence becomes.
Frequently asked questions
Does GHK-Cu really reduce wrinkles?
Multiple small controlled trials of topical GHK-Cu formulations have shown improvements in skin firmness and wrinkle depth over ~12 weeks. Effect sizes are modest but statistically detectable.
Is injectable GHK-Cu safe?
Short-term user reports are generally benign. Systemic and long-term safety data is absent. The mechanism (fibroblast activation, gene upregulation) means some caution is appropriate with repeated systemic administration.
Does GHK-Cu really regrow hair?
Preclinical data is suggestive and a handful of formulations have marketed hair benefits. Rigorous isolated-agent human trials are limited. Expect modest benefit at best relative to established hair-loss treatments (minoxidil, finasteride).
What's special about the copper?
The peptide binds copper with high affinity, and much of its biological activity depends on the copper ion. Copper is a cofactor for multiple dermal remodeling enzymes including lysyl oxidase, which crosslinks collagen and elastin.
References
- Pickart L. The human tri-peptide GHK and tissue remodeling. J Biomater Sci Polym Ed. 2008;19(8):969-88. https://pubmed.ncbi.nlm.nih.gov/18644225/
- Mulder GD, Patt LM, Sanders L, et al. Enhanced healing of ulcers in patients with diabetes by topical treatment with glycyl-l-histidyl-l-lysine copper. Wound Repair Regen. 1994;2(4):259-69. https://pubmed.ncbi.nlm.nih.gov/17147645/
- Leyden J, Stephens TJ, Finkey MB, Barkovic S. Skin care benefits of copper peptide containing facial cream. American Academy of Dermatology Annual Meeting Poster. 2002. (Representative of topical cosmetic trial literature.) https://pubmed.ncbi.nlm.nih.gov/?term=GHK-Cu+skin+trial